Meet-the-Professor Session:
191. Evaluating the Outcomes of Staphylococcus aureus Bacteremia: Use of the DOOR Strategy
Saturday, October 29, 2016: 7:00 AM-8:15 AM
Room: 383-385

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • describe the Desirability of Outcome Ranking (DOOR) strategy
  • apply the DOOR strategy in patients with S. aureus bacteremia
  • explain the benefits and disadvantages of ordinal ranking in comparing outcomes after S. aureus bacteremia

Target Audience: Academicians, Clinicians, Epidemiologists, Fellows, Healthcare workers, Hospital administrators, Hospital epidemiologists, Infection preventionists, Infectious diseases pediatricians, Infectious diseases physicians, Investigators, Members-in-training, Nurses, Pharmacists, Public health practitioners, Researchers, Scientists

Tracks: Adult ID, Epidemiology and Infection Control, Investigative ID, Pediatric ID

Moderators:  Vance G. Fowler Jr., MD, Duke University Medical Center and Henry Chambers, MD, FIDSA, University of California San Francisco, Clinical and Translational Sciences Institute

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™

ACPE Credits:

ACPE Number:

Disclosures:

V. G. Fowler Jr., Pfizer, Novartis, Galderma,: Consultant , Consulting fee
Novadigm, Durata, Debiopharm,: Consultant , Consulting fee
Genentech, Achaogen, Affinium,: Consultant , Consulting fee
Medicines Co., Cerexa, Tetraphase,: Consultant , Consulting fee
Trius, MedImmune, Bayer,: Consultant , Consulting fee
Theravance, Cubist, Basilea,: Consultant , Consulting fee
Affinergy, Janssen, Novartis: Consultant , Consulting fee
Grant Investigator , Research grant
NIH: Grant Investigator , Research support
MedImmune: Grant Investigator , Research grant
Pfizer, Theravance, Karius: Grant Investigator , Research grant
Advanced Liquid Logics: Grant Investigator , Research grant
Novartis, Cubist/Merck: Grant Investigator , Research grant
Medical Biosurfaces: Grant Investigator , Research grant
Locus, Affinergy, Contrafect: Grant Investigator , Research grant
Green Cross: guest speaker , Speaker honorarium
UpToDate: Author , Royalties
Patent Pending - diagnostics: partial owner of patent pending sepsis diagnostics , partial owner of patent pending sepsis diagnostics

H. Chambers, Allergan: Scientific Advisor , Consulting fee
The Medicine Company: Grant Investigator , Research grant
Genentech: Consultant and Grant Investigator , Research grant and Speaker honorarium

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.